Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer

Endocrine-Related Cancer

Volumn 20, Issue 3, 2013, Pages 339-348

  Kim, Sewha ^a   Kim, Do Hee ^a   Jung, Woo Hee ^a   Koo, Ja Seung ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Breast cancer; Glutamine; Metabolism

Indexed keywords

AMINO ACID TRANSPORTER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GLUTAMATE DEHYDROGENASE; GLUTAMINASE; GLUTAMINE; GLUTAMINE METABOLISM RELATED PROTEIN; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER PROGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN METABOLISM; TISSUE MICROARRAY;

BREAST CANCER; GLUTAMINE; METABOLISM;

ADULT; AMINO ACID TRANSPORT SYSTEM ASC; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GLUTAMATE DEHYDROGENASE; GLUTAMINASE; GLUTAMINE; HUMANS; MIDDLE AGED; PHENOTYPE; TISSUE ARRAY ANALYSIS;

EID: 84879491733     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-12-0398     Document Type: Article

References (30)

1. Collins CL, Wasa M, Souba WW & Abcouwer SF 1997 Regulation of glutamine synthetase in human breast carcinoma cells and experimental tumors. Surgery 122 451-463 (discussion 463-464). (doi:10.1016/S0039-6060(97)90039-8)
2. Colombo SL, Palacios-Callender M, Frakich N, Carcamo S, Kovacs I, Tudzarova S & Moncada S 2011 Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells. PNAS 108 21069-21074. (doi:10.1073/pnas. 1117500108)
3. Curthoys NP & Watford M 1995 Regulation of glutaminase activity and glutamine metabolism. Annual Review of Nutrition 15 133-159. (doi:10.1146/annurev.nu.15.070195.001025)
4. Dang CV 2010 Glutaminolysis: supplying carbon or nitrogen or both for cancer cells? Cell Cycle 9 3884-3886. (doi:10.4161/cc.9.19.13302)
5. DeBerardinis RJ & Cheng T 2010 Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29 313-324. (doi:10.1038/onc.2009.358)
6. Elston CW & Ellis IO 1991 Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19 403-410. (doi:10.1111/j.1365-2559.1991.tb00229.x)
7. Eng CH & Abraham RT 2010 Glutaminolysis yields a metabolic by-product that stimulates autophagy. Autophagy 6 968-970. (doi:10.4161/auto.6. 7.13082)
8. Foulkes WD, Smith IE & Reis-Filho JS 2010 Triple-negative breast cancer. New England Journal of Medicine 363 1938-1948. (doi:10.1056/ NEJMra1001389)
9. Friday E, Oliver R, III, Welbourne T & Turturro F 2011 Glutaminolysis and glycolysis regulation by troglitazone in breast cancer cells: relationship to mitochondrial membrane potential. Journal of Cellular Physiology 226 511-519. (doi:10.1002/jcp.22360)
10. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT et al. 2009 c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458 762-765. (doi:10.1038/nature07823)
11. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B & Senn HJ 2011 Strategies for subtypes - dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Annals of Oncology 22 1736-1747. (doi:10.1093/annonc/mdr304)
12. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M et al. 2010 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Journal of Clinical Oncology 28 2784-2795. (doi:10.1200/JCO.2009.25. 6529)
13. Hussein YR, Bandyopadhyay S, Semaan A, Ahmed Q, Albashiti B, Jazaerly T, Nahleh Z & Ali-Fehmi R 2011 Glut-1 expression correlates with basallike breast cancer. Translational Oncology 4 321-327.
14. Ko YH, Lin Z, Flomenberg N, Pestell RG, Howell A, Sotgia F, Lisanti MP & Martinez-Outschoorn UE 2011 Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: Implications for preventing chemotherapy resistance. Cancer Biology & Therapy 12 1085-1097. (doi:10.4161/cbt.12.12.18671)
15. Kung HN, Marks JR & Chi JT 2011 Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. PLoS Genetics 7 e1002229. (doi:10.1371/journal.pgen. 1002229)
16. Marino G & Kroemer G 2010 Ammonia: a diffusible factor released by proliferating cells that induces autophagy. Science Signaling 3 pe19. (doi:10.1126/scisignal.3124pe19)
17. Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Tanowitz HB, Sotgia F & Lisanti MP 2011 Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. International Journal of Biochemistry & Cell Biology 43 1045-1051. (doi:10.1016/j.biocel.2011.01.023)
18. McGivan JD & Bungard CI 2007 The transport of glutamine into mammalian cells. Frontiers in Bioscience 12 874-882. (doi:10.2741/2109)
19. Park K, Kwak K, Kim J, Lim S & Han S 2005 c-myc amplification is associated with HER2 amplification and closely linked with cell proliferation in tissue microarray of nonselected breast cancers. Human Pathology 36 634-639. (doi:10.1016/j.humpath.2005.04.016)
20. Pavlides S, Tsirigos A, Migneco G, Whitaker-Menezes D, Chiavarina B, Flomenberg N, Frank PG, Casimiro MC, Wang C, Pestell RG et al. 2010 The autophagic tumor stroma model of cancer: role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle 9 3485-3505. (doi:10.4161/cc.9.17.12721)
21. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA et al. 2000 Molecular portraits of human breast tumours. Nature 406 747-752. (doi:10.1038/35021093)
22. Pinheiro C, Sousa B, Albergaria A, Paredes J, Dufloth R, Vieira D, Schmitt F & Baltazar F 2011 GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. Histology and Histopathology 26 1279-1286. (doi:10.1016/S1359-6349 (10)71197-6)
23. Rakha EA & Ellis IO 2009 Triple-negative/basal-like breast cancer: review. Pathology 41 40-47. (doi:10.1080/00313020802563510)
24. Reis-Filho JS & Tutt AN 2008 Triple negative tumours: a critical review. Histopathology 52 108-118. (doi:10.1111/j.1365-2559.2007.02889.x)
25. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. PNAS 98 10869-10874. (doi:10.1073/pnas. 191367098)
26. Venkitaraman R 2010 Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features. Expert Review of Anticancer Therapy 10 199-207. (doi:10.1586/era.09.189)
27. Warburg O 1956 On the origin of cancer cells. Science 123 309-314. (doi:10.1126/science.123.3191.309)
28. Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, Nissim I, Daikhin E, Yudkoff M, McMahon SB et al. 2008 Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. PNAS 105 18782-18787. (doi:10.1073/pnas.0810199105)
29. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A et al. 2007 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Journal of Clinical Oncology 25 118-145. (doi:10.1200/JCO.2006.09.2775)
30. Yang C, Sudderth J, Dang T, Bachoo RM, McDonald JG & DeBerardinis RJ 2009 Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Research 69 7986-7993. (doi:10.1158/0008-5472.CAN-09-2266)